GSK plc disclosed the vesting of performance share plan awards for top executives on February 9, 2024, resulting in a total adjusted free cash flow of £9.81 billion, surpassing the target for maximum vesting. The awards were originally granted in February 2021 and required various performance criteria to be met by December 31, 2023.